U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837077) titled 'Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers' on Jan. 07.
Brief Summary: In order to improve the medication convenience and compliance of patients and facilitates in the long-term control of disease condition, it is planned to reduced the number of injections to one per administration. The study aims to compare the safety and pharmacokinetics data to assess feasibility of single-site and multiple-site injection for administration.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Hypercholesterolemia and Hyperlipidemia
Intervention:
DRUG: SHR-1209...